EPI2ME Labs 23.05-01 Release![Stephen Rudd]()
Dear Nanopore Community, With our first release of May, we are delighted to introduce two new…
May 03, 2023
2 min
Published by Author 31
Director, Bioinformatics Product
I engage with Oxford Nanopore Technologies' customers to understand their needs and turn these into EPI2ME Labs products.
Expertise
Bioinformatics
Product Management
EPI2ME Labs 23.04-01 Release![Stephen Rudd]()
We are pleased to release a collection of updates and technical improvements to the EPI2ME Labs…
April 06, 2023
1 min
EPI2ME Labs 23.03-01 Release![Stephen Rudd]()
Our Early March bioinformatics release brings new functionality to the wf-human-variation workflow…
March 08, 2023
2 min
EPI2ME Labs 23.02-02 Release![Stephen Rudd]()
Dear Nanopore community, This second bioinformatics release of February includes a new workflow for…
February 22, 2023
1 min
EPI2ME Labs 23.02-01 Release![Stephen Rudd]()
Dear Nanopore Community, This release Wednesday we are pleased to include CNV detection in our human…
February 08, 2023
1 min
EPI2ME Labs 23.01.01 Release![Stephen Rudd]()
Dear Nanopore Community, The EPI2ME Labs application has been updated to revision v4.1.1. This…
January 25, 2023
1 min
Information
© 2020 - 2024 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.